RecruitingNCT06640764
Multicentre SMS Study - FR
Étude Prospective, Multicentrique, Non contrôlée, Non randomisée, Ouverte évaluant la Performance et la stabilité de l'Implant fémoral Non cimenté SMS
Sponsor
Medacta International SA
Enrollment
260 participants
Start Date
Sep 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Prospective, multicentre, non controled, non randomised, clinical study to assess the performance and the stability of SMS femoral stem
Eligibility
Min Age: 18 YearsMax Age: 85 Years
Inclusion Criteria6
- Patient suffering from a severely painful and/or disabling hip joint due to osteoarthritis, traumatic arthritis, developmental dysplasia of the hip, or avascular necrosis of the femoral head, and requiring a total hip replacement.
- Patient who will receive a Medacta SMS femoral stem.
- Patient agrees to comply with the study requirements.
- Patient has signed the consent form.
- Patient is affiliated with a social security system.
- Patient aged 18 to 75 years
Exclusion Criteria17
- Participation in biomedical research.
- Minor patient.
- Protected adult patient.
- Vulnerable individuals as defined by Article L1121-6 of the Public Health Code.
- Pregnant or breastfeeding women.
- Patient unable to express their non-opposition.
- Patient refusing the collection of their personal data.
- Acute, systemic, or chronic infection. Skeletal immaturity.
- Grossly deformed anatomy (at the surgeon's discretion).
- Osteomalacia for which the fixation of an uncemented implant is contraindicated.
- Patient suffering from active rheumatoid arthritis or osteoporosis.
- Patient with metabolic disorders likely to impair bone formation when the fixation of an uncemented implant is contraindicated.
- Patient suffering from muscle atrophy or neuromuscular disease.
- Patient with an allergy to the implant material.
- Any patient who cannot or does not wish to give their informed consent to participate in the study.
- Patient whose prospects of regaining independent mobility would be compromised by known coexisting medical problems.
- Any contraindication mentioned in the instructions for use of the investigational medical device.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURETotal Hip Arthroplasty
Total Hip Arthroplasty with SMS Femoral Stem (Medacta)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06640764